Skip to main content
Clyde Yancy Jr., MD, Cardiology, Chicago, IL, Northwestern Memorial Hospital

ClydeWarrenYancyJr.MDMSc

Cardiology Chicago, IL

Heart Failure & Transplantation, Preventive Cardiology

Vice-Dean, Diversity and Inclusion, Professor and Chief of Cardiology, - Northwestern University, Feinberg School of Medicine; Associate Director, Bluhm Cardiovascular Institute, Northwestern Medicine; & Deputy Editor, JAMA Cardiology

Dr. Yancy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Yancy's full profile

Already have an account?

Summary

  • Dr. Clyde Yancy is a cardiologist in Chicago, IL and is affiliated with Northwestern Memorial Hospital. He received his medical degree from Tulane University School of Medicine and has been in practice 35 years. He specializes in prevention, heart failure, cardiomyopathies, heart transplantation, health disparities, health policy, outcomes research, and diversity/equity/inclusion. He is a recognized national leader in cardiovascular medicine.

Education & Training

  • University of Texas
    University of TexasMSc, Medical Management, 2008 - 2010
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Cardiovascular Disease, 1986 - 1987
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1982 - 1985
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 1982

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2011 - 2026
  • TX State Medical License
    TX State Medical License 1984 - 2024
  • LA State Medical License
    LA State Medical License 1982 - 2009
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • President American Heart Association, 2009-2010
  • Super Doctor SuperDoctors.com
  • Fellow (FACC) American College of Cardiology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Expediting the Benefits of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure—There Is No Time for Delay  
    Gregg C Fonarow, Clyde W Yancy, JAMA Cardiology
  • Association of the V122I Transthyretin Amyloidosis Genetic Variant with Cardiac Structure and Function in Middle-Aged Black Adults  
    Clyde W Yancy, Elizabeth M Mcnally, Joao Lima, Donald M Lloyd-Jones, Sadiya S Khan, JAMA Cardiology
  • Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients with High-Risk Cardiovascular...  
    Jacob A Udell, Sheila M Hegde, Deepak L Bhatt, J Michael Gaziano, Kristin Nichol, Matthew C Tattersall, Jonathan L Temte, Clyde Yancy, JAMA
  • Join now to see all

Lectures

  • Diversity in Medicine: Charting a Path Forward 
    CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
  • Challenges in Heart Failure: Diagnosis and Management 
    2019 ACP Internal Medicine Meeting, Philadelphia - 4/13/2019
  • Joint American College of Cardiology/Journal of the American Medical Association Late-Breaking Clinical Trials 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Join now to see all

Authored Content

  • Cardiology and COVID-19September 2020
  • Explanation for the Corrections for the Study of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019August 2020
  • Explanation for the Corrections for the Study of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019August 2020
  • The Use of Sacubitril/Valsartan for Hospitalized Heart Failure—Why Do We Care About Cost and Value?August 2020
  • The Use of Sacubitril/Valsartan for Hospitalized Heart Failure—Why Do We Care About Cost and Value?August 2020
  • Coronavirus Disease 2019 (COVID-19) and the Heart—Is Heart Failure the Next Chapter?July 2020
  • Association of Optimal Implementation of Sodium-Glucose Cotransporter 2 Inhibitor Therapy with Outcome for Patients with Heart FailureMay 2020
  • 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure with Reduced Ejection Fraction A Report of the American College of Cardiology Task Force on Expert Consensus Decision PathwaysJanuary 2018
  • 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure with Reduced Ejection FractionDecember 2017
  • Join now to see all

Press Mentions

  • Black Population Accounts for over 1 Million Excess Deaths in Last Two Decades, Study Finds
    Black Population Accounts for over 1 Million Excess Deaths in Last Two Decades, Study FindsMay 21st, 2023
  • Black Americans Dying Too Young
    Black Americans Dying Too YoungMay 18th, 2023
  • Risk of Sudden Cardiac Arrest Rises Sharply in Ventura County
    Risk of Sudden Cardiac Arrest Rises Sharply in Ventura CountyMarch 31st, 2023
  • Join now to see all

Committees

  • member, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

Professional Memberships

Hospital Affiliations